Nordicus Partners (NORD) Return on Assets [ROA] (2011 - 2026)
Nordicus Partners' Return on Assets [ROA] was -6.93% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 1.65 percentage points from -5.28% a year earlier and down 1.58 percentage points from the prior quarter.
Powered by 
Analysis
Nordicus Partners (NORD) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Assets [ROA] at Nordicus Partners came in at -5.55%, up 2.54 percentage points from FY2025.
- Return on Assets [ROA] has now increased for three consecutive fiscal years, with a five-year change of +5.81 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Assets [ROA] was -8.10% in FY2025 (+23.92 pp), -32.02% in FY2024 (+5523.08 pp), -5555.10% in FY2023 (-5403.24 pp) and -151.85% in FY2022 (-140.49 pp).
- The fiscal Q1 2027 figure marks the lowest quarterly Return on Assets [ROA] since fiscal Q4 2024.
- Compared with a year earlier, Return on Assets [ROA] has declined for five straight quarters, with an average year-over-year change of +43.71 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q3 2024 (a gain of 74663.13 percentage points); the worst was fiscal Q3 2023 (a drop of 74283.29 percentage points).
- Per Business Quant data, NORD's Return on Assets [ROA] in the three fiscal quarters before Q1 2027 was -5.35% (Q4 2026), -6.03% (Q3 2026) and -6.41% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.14% |
| 10 | Nordicus Partners | 78.16 Mn | 77.63 Mn | - | -6.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.93% |
| Mar 31, 2026 | -5.35% |
| Dec 31, 2025 | -6.03% |
| Sep 30, 2025 | -6.41% |
| Jun 30, 2025 | -5.28% |
| Mar 31, 2025 | -4.49% |
| Dec 31, 2024 | -5.95% |
| Sep 30, 2024 | -4.45% |
| Jun 30, 2024 | -4.57% |
| Mar 31, 2024 | -16.54% |
| Dec 31, 2023 | -154.55% |
| Sep 30, 2023 | -198.76% |
| Jun 30, 2023 | -377.88% |
| Mar 31, 2023 | -27,766.38% |
| Dec 31, 2022 | -74,817.69% |
| Sep 30, 2022 | -5,227.08% |
| Jun 30, 2022 | -2,408.74% |
| Mar 31, 2022 | -154.30% |
| Dec 31, 2021 | -534.40% |
| Sep 30, 2021 | -1,334.62% |
API Access
Nordicus Partners Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NORD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NORD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NORD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();